North America Home Infusion Therapy Market Size, Share, Development Status, Type and Application, Opportunities, Forecast by 2028

 

The North America home infusion therapy market is expected to grow from US$ 10,954.08 million in 2022 to US$ 18,112.18 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028

Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population is Driving North America Home Infusion Therapy Market

Chronic disorders such as cardiovascular, nutritional, and gastrointestinal disorders, rheumatoid arthritis, and neurological disorders affect the overall quality of life.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/BMIRE00028375

According to the World Health Organization (WHO), over 50% of the global population is estimated to suffer from at least one chronic disease. The Centers for Disease Control and Prevention (CDC) stated that 6 out of 10 people in the US suffered from at least one chronic disease in 2019. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” a large-scale multinational study published in 2021, ~40% of 73,076 adults surveyed from 33 countries in the world were suffering from a functional gastrointestinal disorder (GFID). Age-related gastrointestinal problems are more common in the elderly population, aged 64 and above.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-home-infusion-therapy-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

B. Braun Melsungen AG

Baxter International Inc

Nipro Corp

Becton Dickinson and Co

Fresenius Kabi AG

ICU Medical Inc

JMS Co Ltd

Eitan Medical Ltd

Terumo Corp

The North American home infusion therapy market is experiencing significant growth, primarily driven by two key factors: the escalating prevalence of chronic disorders and the rapidly expanding geriatric population.

Rising Chronic Disease Burden:

  • Chronic diseases, encompassing cardiovascular, nutritional, gastrointestinal, rheumatoid arthritis, and neurological disorders, are significantly impacting quality of life.
  • Global statistics highlight the widespread nature of these conditions, with over 50% of the world's population estimated to have at least one chronic disease (WHO).
  • In the United States, the CDC reports that 6 in 10 adults suffer from at least one chronic disease.
  • Gastrointestinal disorders, particularly prevalent among the elderly, affect a substantial portion of the population, as evidenced by a 2021 global study indicating that approximately 40% of adults surveyed across 33 countries had a functional gastrointestinal disorder.
  • Cardiovascular diseases and diabetes, often exacerbated by modern lifestyles, are major contributors to mortality. The International Diabetes Federation (IDF) reported 537 million people worldwide with diabetes in 2021, projecting a rise to 783 million by 2045.
  • Neurological conditions are also widespread, with approximately 14.7 million cases registered in 2019 in the United Kingdom alone.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

 

𝐀𝐮𝐭𝐡𝐨𝐫’𝐬 𝐁𝐢𝐨:

𝐒𝐰𝐢𝐭𝐢 𝐏𝐚𝐭𝐢𝐥

𝐒𝐞𝐧𝐢𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭

Comments

Post a Comment

Popular posts from this blog

Europe Power Management IC Market- Global Drivers, Opportunities, Trends, and Forecasts to 2028

Image
The power management IC market in Europe is expected to grow from US$ 11,342.18 million in 2021 to US$ 17,503.59 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The adoption of electric vehicles is growing tremendously across the region. Sales of electric vehicles (EVs) have increased in the Europe markets. The Power management plays a significant role with respect to the efficiency of the device, be it an ultra-low-power wireless sensor network or automotive high-voltage power converter. With a rise in requirement for proper power management, companies are looking at manufacturing customized power management integrated chips. The stringent emission norms in European countries are driving the demand for electric vehicles to a notable extent. Thus, respective policies, norms, incentives, and subsidies promote the sales of electric vehicles across the region. A PMIC is widely used in various automotive applications, such as ADAS, infotainment, battery mana...
Read more

Europe Automated Waste Collection Systems Market Size, Share, Trends, Segmentation And Forecast To 2028

Europe automated waste collection systems market in Europe is expected to grow from US$ 103.11 million in 2021 to US$ 150.18 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. Waste collection is an important aspect of waste management, but rates differ a lot based on income levels, with upper-middle- and high-income countries having almost universal waste collection. Different types of waste produced in the world include food waste, glass and green, paper and cardboard, rubber and leather, wood, plastic, and so on. Thus, the rising global waste production is influencing the adoption of technologically advanced solutions such as automatic waste collection systems to collect the waste and manage it for ensuring safety and environmental hygiene of the population. 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00027445 The European region comprise of significant number of automated waste collection ...
Read more

Europe Airway Management Devices Market Size, Share, Challenges, Trend, Segmentation and Forecast to 2028

Image
  The airway management devices market in Europe is expected to grow from US$ 508.81 million in 2022 to US$ 762.14 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028. Rising Prevalence of Respiratory Disorders Europe Airway Management Devices Market Chronic respiratory diseases are among the most prevalent noncommunicable diseases worldwide due to the increase in the noxious environment and occupational and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is the third leading cause of death. The National Health Service states that ~1.17 million people in the UK were diagnosed with COPD in 2021, i.e., ~1.9% of the total population. The rising prevalence of respiratory disorders is driving the demand for airway management devices. Europe A...
Read more